These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Adding exogenous biglycan or decorin improves tendon formation for equine peritenon and tendon proper cells in vitro. Pechanec MY; Boyd TN; Baar K; Mienaltowski MJ BMC Musculoskelet Disord; 2020 Sep; 21(1):627. PubMed ID: 32967653 [TBL] [Abstract][Full Text] [Related]
24. Beta ig-h3 interacts directly with biglycan and decorin, promotes collagen VI aggregation, and participates in ternary complexing with these macromolecules. Reinboth B; Thomas J; Hanssen E; Gibson MA J Biol Chem; 2006 Mar; 281(12):7816-24. PubMed ID: 16434404 [TBL] [Abstract][Full Text] [Related]
25. Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Salgado RM; Favaro RR; Zorn TM Reprod Biol Endocrinol; 2011 Feb; 9():22. PubMed ID: 21294898 [TBL] [Abstract][Full Text] [Related]
26. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer. Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis. Stokes MB; Hudkins KL; Zaharia V; Taneda S; Alpers CE Kidney Int; 2001 Feb; 59(2):532-42. PubMed ID: 11168935 [TBL] [Abstract][Full Text] [Related]
28. Differential roles for small leucine-rich proteoglycans in bone formation. Waddington RJ; Roberts HC; Sugars RV; Schönherr E Eur Cell Mater; 2003 Oct; 6():12-21; discussion 21. PubMed ID: 14562268 [TBL] [Abstract][Full Text] [Related]
29. Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice. Zhang Y; Mori T; Iseki K; Hagino S; Takaki H; Takeuchi M; Hikake T; Tase C; Murakawa M; Yokoya S; Wanaka A Dev Dyn; 2003 Apr; 226(4):618-26. PubMed ID: 12666199 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. Corsi A; Xu T; Chen XD; Boyde A; Liang J; Mankani M; Sommer B; Iozzo RV; Eichstetter I; Robey PG; Bianco P; Young MF J Bone Miner Res; 2002 Jul; 17(7):1180-9. PubMed ID: 12102052 [TBL] [Abstract][Full Text] [Related]
31. Fibromodulin regulates collagen fibrillogenesis during peripheral corneal development. Chen S; Oldberg A; Chakravarti S; Birk DE Dev Dyn; 2010 Mar; 239(3):844-54. PubMed ID: 20108350 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of decorin and biglycan genes during mouse tooth development. Matsuura T; Duarte WR; Cheng H; Uzawa K; Yamauchi M Matrix Biol; 2001 Sep; 20(5-6):367-73. PubMed ID: 11566271 [TBL] [Abstract][Full Text] [Related]
33. Mechanical Response of Mouse Cervices Lacking Decorin and Biglycan During Pregnancy. Lee N; Shi L; Colon Caraballo M; Nallasamy S; Mahendroo M; Iozzo RV; Myers K J Biomech Eng; 2022 Jun; 144(6):. PubMed ID: 35348624 [TBL] [Abstract][Full Text] [Related]
34. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Sugars RV; Milan AM; Brown JO; Waddington RJ; Hall RC; Embery G Connect Tissue Res; 2003; 44 Suppl 1():189-95. PubMed ID: 12952196 [TBL] [Abstract][Full Text] [Related]
35. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Rada JA; Cornuet PK; Hassell JR Exp Eye Res; 1993 Jun; 56(6):635-48. PubMed ID: 8595806 [TBL] [Abstract][Full Text] [Related]
36. Genetic evidence for key roles of decorin and biglycan in dentin mineralization. Haruyama N; Sreenath TL; Suzuki S; Yao X; Wang Z; Wang Y; Honeycutt C; Iozzo RV; Young MF; Kulkarni AB Matrix Biol; 2009 Apr; 28(3):129-36. PubMed ID: 19379665 [TBL] [Abstract][Full Text] [Related]
37. The tendon injury response is influenced by decorin and biglycan. Dunkman AA; Buckley MR; Mienaltowski MJ; Adams SM; Thomas SJ; Satchell L; Kumar A; Pathmanathan L; Beason DP; Iozzo RV; Birk DE; Soslowsky LJ Ann Biomed Eng; 2014 Mar; 42(3):619-30. PubMed ID: 24072490 [TBL] [Abstract][Full Text] [Related]
38. Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Stokes MB; Holler S; Cui Y; Hudkins KL; Eitner F; Fogo A; Alpers CE Kidney Int; 2000 Feb; 57(2):487-98. PubMed ID: 10652025 [TBL] [Abstract][Full Text] [Related]
39. Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. Svensson L; Heinegård D; Oldberg A J Biol Chem; 1995 Sep; 270(35):20712-6. PubMed ID: 7657652 [TBL] [Abstract][Full Text] [Related]
40. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]